Bedaquiline-Pretomanid-Linezolid Regimens Compared for XDR TB
Overall risk-benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.